Data from Phase 2 BESTOW trial demonstrated a favorable safety and tolerability profile, substantially reducing the metabolic, neurologic, and ...

FDA Approval to Advance Final FemBloc® Trial with Clear Pathway to Potentially Achieve U.S. FDA Approval –– $12 Million Financing Strengthens ...

Q3 2025 Earnings Call November 13, 2025 4:30 PM ESTCompany ParticipantsMarDee Haring-Layton - Chief Accounting ...

Objective To assess the effects of behaviourally informed short message service (SMS) reminders on demand for human ...

Q3 2025 Earnings Call Transcript November 12, 2025 BiomX Inc. beats earnings expectations. Reported EPS is $0, expectations ...

Reported net loss was $9.0 million, or $0.19 per basic and diluted share, for the three months ended September 30, 2025, compared to $10.7 million, or $0.29 per basic share and diluted share, for the ...

In a secondary analysis of the denifanstat phase 2b FASCINATE-2 clinical trial, denifanstat elicited a significant =2-stage improvement in fibrosis in F3 MASH patients, and improved liver fibrosis and ...

When he talks about Pat Williams, former Montana Gov. Brian Schweitzer likes to retell a story he heard from Chuck Johnson.

Operating Income Pressure -- Operating income decreased to $1.6 million from $2.6 million compared to the prior year period, ...

The plaintiff Cup Series teams notched a win Tuesday against NASCAR. Here’s a close look at what will be discussed and disclosed at trial.

Q3 2025 Earnings Call Transcript November 3, 2025 Karyopharm Therapeutics Inc. misses on earnings expectations. Reported EPS ...

Money has shaped the justice system for centuries through common law tort principles that balance financial restitution with moral accountability. But over several decades, that balance has collapsed.